Skip to main content
Caplight Logo









Fuse Diagnostics

Fuse Diagnostics

Private
CambridgeHealthcare & Life Scienceshttps://fuse-dx.com/

Last Round

Grant

Jun 13, 2024

Total Funding Raised

$2.03M

Company Overview

Fuse Diagnostics is a biotechnology company that develops rapid, low-cost, instrument-free molecular diagnostic platforms for industrial, clinical, and veterinary applications.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Healthcare Analytics, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Non-AI

Keywords

point-of-care diagnosticsPOC testingmedical diagnostic hardwarerapid diagnostic testingdiagnostic test kitsclinical diagnosticsmedical devicedata management softwarerazor-and-blade modelhealthcare analyticsportable labclinical decision supportlab-on-a-chipdecentralized clinical trialshealth IoT

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Fuse Diagnostics Comparables

Compare Fuse Diagnostics with similar companies based on industry and business-model similarity.

Fuse Diagnostics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Prompt Diagnostics
83%
QuantuMDx
79%
VedaBio
79%

Fuse Diagnostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 13, 2024
SeedMay 29, 2024

Key People

Founding team and executive leadership

Ralph Lamble

Chief Operating Officer

Executive Team

Fuse Diagnostics Investors

Notable investors and investment history

Fuse Diagnostics investors
InvestorRounds
CARB-XGrant
Innovate UKSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 14, 2025

    Grew 25% QoQ, from 12 to 15 employees.

  • Apr 16, 2025

    Monthly visitors grew 152% MoM.

Fuse Diagnostics Filings

Explore SEC and related filing metadata, where available.

Fuse Diagnostics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Fuse Diagnostics's valuation, stock price, and market status.

Is Fuse Diagnostics a public or private company?

Fuse Diagnostics is a private company.

What is the current stock price of Fuse Diagnostics?

Fuse Diagnostics is a private company with no public stock price. Caplight tracks Fuse Diagnostics's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Fuse Diagnostics worth (valuation)?

Valuation information for Fuse Diagnostics is not publicly available.

Can I buy Fuse Diagnostics stock?

Fuse Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Fuse Diagnostics's last funding round?

Fuse Diagnostics's most recent funding round was Grant on June 13, 2024.

Who are the main investors in Fuse Diagnostics?

Key investors in Fuse Diagnostics include CARB-X, Innovate UK.

Will Fuse Diagnostics IPO soon?

No public IPO plans have been announced for Fuse Diagnostics.

How can I track Fuse Diagnostics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Fuse Diagnostics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge
Employee Range15
Year Founded2022
Last FundingJun 13, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?